Best New Pain Management Technologies for 2026
This year’s Pain Management Technology Awards winners take on pain from three directions: a stimulation electrode placed through a needle, a disposable kit for decompressing the lu...
This year’s Pain Management Technology Awards winners take on pain from three directions: a stimulation electrode placed through a needle, a disposable kit for decompressing the lu...
Vivex matched 1,804 Medicare patients treated with VIA Disc NP against 1,804 managed with conservative care. Opioid supply, imaging, injections, and physical therapy all dropped in...
Pain management specialist Dr. Hany Demian and Dr. Laura Cordero Jordà, PhD, will host a free public webinar on October 29 exploring emerging research on PRP-derived exosomes and t...
A randomized trial in The Journal of Bone and Joint Surgery pits two pain management techniques against each other.
A truly novel treatment for pain associated with knee osteoarthritis was just granted its own, entirely new 510(k) device category.
FAIR LAWN, NJ, UNITED STATES, October 20, 2026 /EINPresswire.com/ — Alliance Orthopedics announces the addition of Dr. Alec Cartagena,…
Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the publication of a milestone study.
Chronic lower back pain is one of the most common and costly medical conditions, and degeneration of the intervertebral discs is a frequent underlying cause.
TLC BioSciences Corp. today announced positive topline results from its pivotal Phase 3 trial of TLC590.
Dr. Alec Cartagena joins Alliance Orthopedics bringing extensive procedural experience and expertise in complex spine conditions.
Results showed patients who received erector spinae plane block consumed fewer opioids on postoperative day 0 after minimally invasive transforaminal lumbar interbody fusion.“From...
DALLAS — Results showed Reneurx nerve-selective therapy may be safe and effective for pain associated with knee osteoarthritis with better pain reduction and functional outcomes co...
The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability.
Dr. Kenneth Pettine, CEO of Direct Regeneration, announced a landmark portfolio of technologies poised to revolutionize the treatment of osteoarthritis, chronic pain...
Chronic back and neck pain impacts daily activities and quality of life. Effective management includes accurate diagnosis, radiofrequency ablation, physical therapy, and targeted i...
A case report describes a woman with multiple sclerosis–related trigeminal neuralgia who remained free of operated-side pain 43 months after combined internal neurolysis and target...
September is Pain Management Awareness Month, and Intermountain Health Connect Care is helping patients understand and manage pain virtually. The post Patients Experiencing Chronic...
As a prominent health care educator and patient advocate, I receive multiple pleas every month for help locating a doctor who is still accepting patients for pain care in the curre...
Proceeds will fund completion of the Phase 1 trial and continued development of C-1101, a potential first-in-class disease-modifying therapeutic -- Clinical data expected in 1H 202...
A new narrative review maps which transarterial embolization uses in musculoskeletal care are established, which are intermediate, and which remain exploratory.
Aclarion, Inc., announced the publication of a new, independent, peer-reviewed study, “MR Spectroscopy in the Diagnosis of Lumbar Discogenic Pain.”
Multi-modal-analgesia for pain management after Hallux Valgus surgery: a prospective randomised study on the effect of ankle block Ibrahim Turan , Hamid Assareh , Christer Rolf...
By Pat AnsonThe first clinical trials in the United States for a cannabis-based medicine for chronic pain are getting underway.New York State has authorized a clinical trial of VER...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.